Insights Into Multiple Myeloma (MM)

Perspectives on current treatment practices regarding frontline therapy of MM, the evolving role of MRD testing in MM, treatment in later lines of therapy, and attitudes toward recently introduced agents

Southeast – March 10, 2023

Faculty Chair

Jonathan Kaufman, MD

Winship Cancer Institute, Atlanta, GA, USA

Central – April 22, 2023

Faculty Chair

Hans Lee, MD

MD Anderson Cancer Center, Houston, TX, USA

Northeast #1 – July 19, 2023

Faculty Chair

Gareth Morgan, MD

NYU Langone, New York, NY, USA

Faculty Chair

Saad Usmani, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Northeast #2 – July 26, 2023

Faculty Chair

Gareth Morgan, MD

NYU Langone, New York, NY, USA

Faculty Chair

Saad Usmani, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

St Louis Summit – August 5, 2023

Faculty Chair

Ravi Vij, MD

Washington University School of Medicine

Midwest – August 25, 2023

Faculty Chair

David Dingli, MD, PhD

Mayo Clinic, Rochester, MN, USA

California – September 9, 2023

Faculty Chair

Amrita Krishnan, MD

City of Hope Comprehensive Cancer Center, Duarte, CA, USA

Southeast – September 9, 2023

Faculty Chair

Melhem Solh, MD

Northside Hospital, Atlanta, GA, USA

Northeast #3 – September 9, 2023

Faculty Chair

Brea Lipe, MD

University of Rochester Medical Center, Rochester, NY, USA

Faculty Chair

Josh Richter, MD

The Mount Sinai Hospital, New York, NY, USA

Northeast #4 – October 14, 2023

Faculty Chair

Gareth Morgan, MD

NYU Langone, New York, NY, USA

Faculty Chair

Alfred Garfall, MD

Hospital of the University of Pennsylvania, Philadelphia, PA, USA

More Information

  • Atlanta, GA
  • Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia

More Information

  • Dallas, TX
  • Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana

More Information

  • Virtual series
  • Connecticut, Delaware, District of Columbia, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

More Information

  • Virtual series
  • Connecticut, Delaware, District of Columbia, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

More Information

  • Philadelphia, PA
  • Connecticut, Delaware, District of Columbia, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

Example Agenda

Download the meeting agenda

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A moderated roundtable discussion focusing on the treatment of MM
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies are obtained: bortezomib, carfilzomib, ixazomib, elotuzumab, daratumumab, lenalidomide, pomalidomide, thalidomide, melphalan, cyclophosphamide, bendamustine, panobinostat, selinexor, isatuximab, and venetoclax

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.